window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Cell Therapy

  • Advanced Therapies

    Cherwell introduces Redipor TwistLock plate range to aid microbial environmental monitoring

    Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

    May 5, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Chrysalis launches following cleanroom asset acquisition and strategic investment

    Chrysalis, a GMP-compliant space and service provider, has formally launched [...]

    May 5, 2026
  • Advanced Therapies,Manufacturing & Supply Chain

    MaxCyte and Ori Biotech integrate platforms to improve cell therapy manufacturing

    CD19 CAR CRISPR T cell workflow used to demonstrate shortened [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    MaaT Pharma submits EMA application for Xervyteg in graft-versus-host disease

    MaaT Pharma has submitted a marketing authorisation application (MAA) to [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Limula secures US patent for automated cell therapy manufacturing tech

    Limula has confirmed the granting of a core patent in [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Cellares brings automated CAR-T manufacturing to Japan with first IDMO Smart Factory

    Cellares and Mitsui Fudosan have announced plans to establish Japan’s [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Opinion & Events

    Cellino and Karis Bio join forces to deliver personalized cell therapy in Asia-Pacific

    Cellino and Karis Bio have announced a strategic partnership to [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 5, 2026
  • Advanced Therapies,Opinion & Events

    CAR T Vision coalition sets goal to double access to therapy by 2030

    A new international alliance, CAR T Vision, launched today with [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    ScaleReady awards multiple G-Rex grants to USC and Children’s Hospital of Los Angeles Investigators

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and [...]

    May 5, 2026
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cytomos highlights AuraCyt platform for predictive cell analytics at BIO 2026
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain
  • Pheno Therapeutics gains FDA clearance for first-in-human multiple sclerosis drug PTD802
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • ViiV Healthcare gains FDA Priority Review for paediatric Tivicay expansion to newborns
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top